These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 21484168)

  • 1. [Autism and ADHD across the life span. Differential diagnoses or comorbidity?].
    Banaschewski T; Poustka L; Holtmann M
    Nervenarzt; 2011 May; 82(5):573-80. PubMed ID: 21484168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacotherapy of attention-deficit/hyperactivity disorder (ADHD) and comorbid disorders].
    Wiesegger G; Kienbacher C; Pellegrini E; Scheidinger H; Vesely C; Bangerl W; Friedrich M
    Neuropsychiatr; 2007; 21(3):187-206. PubMed ID: 17915180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized double-blind study of atomoxetine versus placebo for attention-deficit/hyperactivity disorder symptoms in children with autism spectrum disorder.
    Harfterkamp M; van de Loo-Neus G; Minderaa RB; van der Gaag RJ; Escobar R; Schacht A; Pamulapati S; Buitelaar JK; Hoekstra PJ
    J Am Acad Child Adolesc Psychiatry; 2012 Jul; 51(7):733-41. PubMed ID: 22721596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atomoxetine for attention-deficit/hyperactivity disorder symptoms in children with pervasive developmental disorders: a pilot study.
    Troost PW; Steenhuis MP; Tuynman-Qua HG; Kalverdijk LJ; Buitelaar JK; Minderaa RB; Hoekstra PJ
    J Child Adolesc Psychopharmacol; 2006 Oct; 16(5):611-9. PubMed ID: 17069549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term treatment with atomoxetine for attention-deficit/hyperactivity disorder symptoms in children and adolescents with autism spectrum disorder: an open-label extension study.
    Harfterkamp M; Buitelaar JK; Minderaa RB; van de Loo-Neus G; van der Gaag RJ; Hoekstra PJ
    J Child Adolesc Psychopharmacol; 2013 Apr; 23(3):194-9. PubMed ID: 23578015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Autism and attention deficit hyperactivity disorder: pharmacological intervention].
    Fernández-Jaén A; Martín Fernández-Mayoralas D; Fernández-Perrone AL; Calleja-Pérez B; Muñoz-Jareño N; López-Arribas S
    Rev Neurol; 2013 Sep; 57 Suppl 1():S205-10. PubMed ID: 23897149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tic exacerbation and precipitation during atomoxetine treatment in two children with attention-deficit hyperactivity disorder.
    Párraga HC; Párraga MI; Harris DK
    Int J Psychiatry Med; 2007; 37(4):415-24. PubMed ID: 18441629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Open-label atomoxetine for attention-deficit/ hyperactivity disorder symptoms associated with high-functioning pervasive developmental disorders.
    Posey DJ; Wiegand RE; Wilkerson J; Maynard M; Stigler KA; McDougle CJ
    J Child Adolesc Psychopharmacol; 2006 Oct; 16(5):599-610. PubMed ID: 17069548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The comorbidity of ADHD and autism spectrum disorder.
    Antshel KM; Zhang-James Y; Faraone SV
    Expert Rev Neurother; 2013 Oct; 13(10):1117-28. PubMed ID: 24117274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychopharmacological treatment of ADHD symptoms in children with autism spectrum disorder.
    Handen BL; Taylor J; Tumuluru R
    Int J Adolesc Med Health; 2011; 23(3):167-73. PubMed ID: 22191179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comorbid oppositional defiant disorder and the risk of relapse during 9 months of atomoxetine treatment for attention-deficit/hyperactivity disorder.
    Hazell P; Zhang S; Wolańczyk T; Barton J; Johnson M; Zuddas A; Danckaerts M; Ladikos A; Benn D; Yoran-Hegesh R; Zeiner P; Michelson D
    Eur Child Adolesc Psychiatry; 2006 Mar; 15(2):105-10. PubMed ID: 16523251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atomoxetine for treating ADHD symptoms in autism: a systematic review.
    Ghanizadeh A
    J Atten Disord; 2013 Nov; 17(8):635-40. PubMed ID: 22544388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [My child is so restless].
    Schlamp D
    MMW Fortschr Med; 2007 Mar; 149(10):39-40. PubMed ID: 17408047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atomoxetine versus placebo in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: a double-blind, randomized, multicenter trial in Germany.
    Dittmann RW; Schacht A; Helsberg K; Schneider-Fresenius C; Lehmann M; Lehmkuhl G; Wehmeier PM
    J Child Adolesc Psychopharmacol; 2011 Apr; 21(2):97-110. PubMed ID: 21488751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of pharmacotherapy options for the treatment of attention-deficit/hyperactivity disorder (ADHD) and ADHD-like symptoms in children and adolescents with developmental disorders.
    Rowles BM; Findling RL
    Dev Disabil Res Rev; 2010; 16(3):273-82. PubMed ID: 20981766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attention-deficit/Hyperactivity Disorder in the context of Autism spectrum disorders.
    Murray MJ
    Curr Psychiatry Rep; 2010 Oct; 12(5):382-8. PubMed ID: 20694583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atomoxetine treatment for pediatric patients with attention-deficit/hyperactivity disorder with comorbid anxiety disorder.
    Geller D; Donnelly C; Lopez F; Rubin R; Newcorn J; Sutton V; Bakken R; Paczkowski M; Kelsey D; Sumner C
    J Am Acad Child Adolesc Psychiatry; 2007 Sep; 46(9):1119-1127. PubMed ID: 17712235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of ADHD symptoms on autism spectrum disorder symptom severity.
    Sprenger L; Bühler E; Poustka L; Bach C; Heinzel-Gutenbrunner M; Kamp-Becker I; Bachmann C
    Res Dev Disabil; 2013 Oct; 34(10):3545-52. PubMed ID: 23973801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atomoxetine may improve methylphenidates' efficacy in treatment of ADHD?
    Niederhofer H
    Psychiatr Danub; 2009 Sep; 21(3):330. PubMed ID: 19794351
    [No Abstract]   [Full Text] [Related]  

  • 20. Response to atomoxetine in boys with high-functioning autism spectrum disorders and attention deficit/hyperactivity disorder.
    Zeiner P; Gjevik E; Weidle B
    Acta Paediatr; 2011 Sep; 100(9):1258-61. PubMed ID: 21392103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.